Completed PHASE2 INTERVENTIONAL 2-arm NCT00680706

Thiamine and Acute Decompensated Heart Failure: Pilot Study

Targeting Myocardial Energy Metabolism for the Treatment of Acute Heart Failure: The Effect of Thiamine on Biochemical, Electrocardiographic and Respiratory Parameters in Hospitalized Patients.

Sponsor: Baystate Medical Center

Conditions Diabetes Heart Failure

Interventions Placebo Thiamine

Updated 7 times since 2017 Last updated: Aug 12, 2013 Started: Jan 31, 2008 Primary completion: Feb 28, 2010 Completion: Jun 30, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Diabetes and Heart Failure and is currently completed. Baystate Medical Center leads this study, which shows 7 recorded versions since 2008 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2023 — Jul 2024 [monthly]

Completed PHASE2
Dec 2022 — Jan 2023 [monthly]

Completed PHASE2
Jan 2021 — Dec 2022 [monthly]

Completed PHASE2

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Jan 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baystate Medical Center
Beth Israel Deaconess Medical Center

Data source: Baystate Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Boston, United States
• Springfield, United States